Can a heartburn pill prevent a rare but deadly surgery complication?
NCT ID NCT06743243
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 26 times
Summary
This study tests whether a drug called tegoprazan can reduce stomach acid during general anesthesia better than another drug (famotidine) or a placebo. The goal is to lower the risk of stomach contents entering the lungs, a rare but serious complication. About 174 adults having planned surgery will take the drug before anesthesia, and their stomach acid levels will be measured right after breathing tube placement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Korea University Medical Center, Guro Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.